GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » FibroBiologics Inc (STU:SG0) » Definitions » Scaled Net Operating Assets

FibroBiologics (STU:SG0) Scaled Net Operating Assets : -0.38 (As of Sep. 2024)


View and export this data going back to 2024. Start your Free Trial

What is FibroBiologics Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

FibroBiologics's operating assets for the quarter that ended in Sep. 2024 was €2.38 Mil. FibroBiologics's operating liabilities for the quarter that ended in Sep. 2024 was €5.56 Mil. FibroBiologics's Total Assets for the quarter that ended in Jun. 2024 was €8.28 Mil. Therefore, FibroBiologics's scaled net operating assets (SNOA) for the quarter that ended in Sep. 2024 was -0.38.


FibroBiologics Scaled Net Operating Assets Historical Data

The historical data trend for FibroBiologics's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

FibroBiologics Scaled Net Operating Assets Chart

FibroBiologics Annual Data
Trend Dec21 Dec22 Dec23
Scaled Net Operating Assets
-0.85 2.88 -1.24

FibroBiologics Quarterly Data
Dec21 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Scaled Net Operating Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 0.12 -0.45 -0.84 -0.58 -0.38

Competitive Comparison of FibroBiologics's Scaled Net Operating Assets

For the Biotechnology subindustry, FibroBiologics's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


FibroBiologics's Scaled Net Operating Assets Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, FibroBiologics's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where FibroBiologics's Scaled Net Operating Assets falls into.



FibroBiologics Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

FibroBiologics's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2023 is calculated as

Scaled Net Operating Assets (SNOA)(A: Dec. 2023 )
=(Operating Assets (A: Dec. 2023 )-Operating Liabilities (A: Dec. 2023 ))/Total Assets (A: Dec. 2022 )
=(2.438-8.089)/4.554
=-1.24

where

Operating Assets(A: Dec. 2023 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=10.84 - 8.402
=2.438

Operating Liabilities(A: Dec. 2023 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=9.691 - 1.27 - 0.332
=8.089

FibroBiologics's Scaled Net Operating Assets (SNOA) for the quarter that ended in Sep. 2024 is calculated as

Scaled Net Operating Assets (SNOA)(Q: Sep. 2024 )
=(Operating Assets (Q: Sep. 2024 )-Operating Liabilities (Q: Sep. 2024 ))/Total Assets (Q: Jun. 2024 )
=(2.381-5.559)/8.279
=-0.38

where

Operating Assets(Q: Sep. 2024 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=9.433 - 7.052
=2.381

Operating Liabilities(Q: Sep. 2024 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=6.967 - 0.951 - 0.457
=5.559

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


FibroBiologics Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of FibroBiologics's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


FibroBiologics Business Description

Traded in Other Exchanges
Address
455 E. Medical Center Boulevard, Suite 300, Houston, TX, USA, 77598
FibroBiologics Inc is a clinical-stage cell therapy company focused on developing and commercializing fibroblast-based therapies for patients suffering from chronic diseases with significant unmet medical needs, including degenerative disc disease, multiple sclerosis, wound healing, and certain cancers, and potential extension of life applications including thymic and splenic involution reversal.

FibroBiologics Headlines

No Headlines